Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

169 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation.
Marrocco DL, Tilley WD, Bianco-Miotto T, Evdokiou A, Scher HI, Rifkind RA, Marks PA, Richon VM, Butler LM. Marrocco DL, et al. Among authors: rifkind ra. Mol Cancer Ther. 2007 Jan;6(1):51-60. doi: 10.1158/1535-7163.MCT-06-0144. Epub 2007 Jan 11. Mol Cancer Ther. 2007. PMID: 17218635 Free article.
Histone deacetylase inhibitors as new cancer drugs.
Marks PA, Richon VM, Breslow R, Rifkind RA. Marks PA, et al. Among authors: rifkind ra. Curr Opin Oncol. 2001 Nov;13(6):477-83. doi: 10.1097/00001622-200111000-00010. Curr Opin Oncol. 2001. PMID: 11673688 Review.
169 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page